https://www.biospace.com/article/releases/revive-therapeutics-provides-update-on-its-cannabinoid-program-initiatives-for-drug-delivery-and-in-the-prevention-of-ischemia-and-reperfusion-injury-from-organ-transplantation
https://www.biospace.com/article/releases/tetra-bio-pharma-provides-update-on-its-commercialization-plan-for-its-otc-din-and-nhp-product-programs
https://www.biospace.com/article/releases/crescita-signs-exclusive-distribution-agreement-with-fillmed
https://www.biospace.com/article/releases/zomedica-successfully-completes-development-and-manufacturing-milestones-for-its-cancer-liquid-biopsy-platformintends-to-seek-commercialization-partner-for-platform
https://www.biospace.com/article/south-korea-s-celltrion-to-launch-a-biosimilar-per-year-for-10-years
https://www.biospace.com/article/clinical-catch-up-january-13-17
https://www.biospace.com/article/fda-action-alert-epizyme-and-merck
https://www.biospace.com/article/releases/global-gynecological-cancers-therapeutics-market-2019-2023-evolving-opportunities-with-astrazeneca-and-glaxosmithkline-plc-technavio
https://www.biospace.com/article/releases/jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-solriamfetol-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea
https://www.biospace.com/article/releases/xrhealth-and-va-st-louis-healthcare-system-partner-to-provide-vr-therapy-to-veterans
https://www.biospace.com/article/releases/nevro-names-donald-a-middlebrook-to-lead-clinical-regulatory-and-quality
https://www.biospace.com/article/common-and-inexpensive-cancer-drug-may-be-key-to-treatment-resistant-leukemia
https://www.biospace.com/article/i-have-a-dream-five-dreams-for-biotech
https://www.biospace.com/article/releases/venus-medtech-announces-the-addition-of-two-cardiovascular-experts-to-their-advisory-team
https://www.biospace.com/article/releases/chi-med-announces-that-surufatinib-phase-iii-sanet-p-study-has-already-achieved-its-primary-endpoint-in-advanced-pancreatic-neuroendocrine-tumors-in-china-and-will-stop-early
https://www.biospace.com/article/releases/tennor-therapeutics-received-fda-orphan-drug-designation
https://www.biospace.com/article/releases/inmed-first-to-advance-cannabinol-cbn-into-therapeutic-clinical-trials
https://www.biospace.com/article/releases/medivir-s-phase-ii-study-of-miv-711-in-patients-with-osteoarthritis-published-in-annals-of-internal-medicine
https://www.biospace.com/article/releases/exmceuticals-inc-appoints-nick-davis-as-board-advisor
https://www.biospace.com/article/releases/varex-schedules-first-quarter-fiscal-year-2020-earnings-release-and-conference-call
https://www.biospace.com/article/astrazeneca-s-combination-treatment-for-hcc-snags-orphan-drug-designation
https://www.biospace.com/article/releases/resaphene-suisse-ag-charite-ethics-committee-in-berlin-approves-study-on-tinniwell-tinnitus-therapy
https://www.biospace.com/article/releases/lexicon-pharmaceuticals-announces-poster-presentation-at-the-asco-2020-gastrointestinal-cancers-symposium
https://www.biospace.com/article/releases/neurocrine-biosciences-announces-conference-call-and-webcast-of-fourth-quarter-and-year-end-2019-financial-results
https://www.biospace.com/article/releases/axonics-announces-fda-approval-of-enhanced-neurostimulator-programmer-
https://www.biospace.com/article/releases/obi-pharma-granted-u-s-fda-orphan-drug-designation-for-the-treatment-of-gastric-cancer-for-its-antibody-drug-conjugate-adc-targeted-cancer-therapy-obi-999
https://www.biospace.com/article/releases/cipher-pharmaceuticals-receives-notice-of-termination-from-bausch
https://www.biospace.com/article/releases/avivagen-announces-update-on-private-placement-process
https://www.biospace.com/article/releases/inotrem-secures-strategic-licensing-agreement-for-a-companion-diagnostics-test-in-septic-shock
https://www.biospace.com/article/releases/calidi-biotherapeutics-secures-series-a-investments-to-advance-manufacturing
https://www.biospace.com/article/releases/onxeo-publishes-shareholder-newsletter
https://www.biospace.com/article/releases/cue-biopharma-announces-publication-in-clinical-cancer-research-of-preclinical-and-translational-data-supporting-the-therapeutic-potential-of-cue-101-in-hpv16-related-malignancies
https://www.biospace.com/article/releases/abeona-therapeutics-announces-participation-in-inaugural-world-congress-on-epidermolysis-bullosa
https://www.biospace.com/article/releases/fda-accepts-evoke-pharma-s-nda-resubmission-for-gimoti-pdufa-target-goal-date-is-june-19-2020
https://www.biospace.com/article/releases/airos-medical-granted-fda-510k-clearance-to-market-compression-device-for-lymphedema-treatment
https://www.biospace.com/article/releases/new-study-published-on-nature-medicine-unveils-the-power-of-ai-in-predicting-osteoporotic-fractures
https://www.biospace.com/article/after-12-million-in-incentives-eli-lilly-adding-462-jobs-in-durham-north-carolina
https://www.biospace.com/article/releases/novocure-announces-national-reimbursement-in-israel-for-optune-in-combination-with-temozolomide-for-the-treatment-of-newly-diagnosed-glioblastoma
https://www.biospace.com/article/releases/dexcom-schedules-fourth-quarter-and-full-year-2019-earnings-release-and-conference-call-for-february-13-2020-at-4-30-p-m-eastern-time
https://www.biospace.com/article/releases/vivalnk-announces-world-s-first-fda-cleared-wearable-ecg-sensor-platform
https://www.biospace.com/article/releases/aldeyra-therapeutics-announces-first-patient-enrolled-in-the-phase-3-invigorate-trial-in-allergic-conjunctivitis
https://www.biospace.com/article/releases/mycovia-pharmaceuticals-expands-commercialization-team-with-strategic-new-hires
https://www.biospace.com/article/releases/seattle-genetics-to-host-conference-call-and-webcast-discussion-of-fourth-quarter-and-full-year-2019-financial-results-on-february-6-2020
https://www.biospace.com/article/releases/anokion-announces-fda-clearance-of-ind-application-for-its-lead-program-in-celiac-disease
https://www.biospace.com/article/releases/advaxis-inc-announces-pricing-of-10-5-million-registered-direct-offering
https://www.biospace.com/article/releases/wize-pharma-completes-patient-enrollment-in-phase-iv-study-of-lo2a-for-the-treatment-of-dry-eye-syndrome-in-patients-with-sjogren-s-syndrome
https://www.biospace.com/article/releases/first-study-of-thoraguard-digital-drainage-system-completed-at-stanford-university-medical-center
https://www.biospace.com/article/releases/biosig-to-present-at-the-25th-annual-international-af-symposiumpure-ep-tm-system-to-be-highlighted-in-a-spotlight-session-by-andrea-natale-m-d-texas-cardiac-arrhythmia-institute
https://www.biospace.com/article/releases/brainstorm-cell-therapeutic-s-coo-and-cmo-dr-ralph-kern-to-present-at-the-10th-annual-california-als-research-summit
https://www.biospace.com/article/takeda-r-and-d-head-doesn-t-see-a-blockbuster-in-its-hemophilia-a-gene-therapy-but-does-see-big-things-coming
https://www.biospace.com/article/releases/emphycorp-n115-rx-globally-patented-non-steroidal-nasal-spray-with-no-known-side-effects-for-pregnant-women-with-allergic-rhinitis-or-asthma
https://www.biospace.com/article/releases/denovo-biopharma-enters-into-option-agreement-with-rumpus-therapeutics-for-selected-db102-enzastaurin-clinical-indications
https://www.biospace.com/article/releases/oncosec-sends-letter-urging-shareholders-not-to-be-distracted-by-alpha-s-last-ditch-efforts-to-derail-cgp-sirtex-transaction-
https://www.biospace.com/article/releases/northstar-medical-technologies-to-present-at-upcoming-emerging-medtech-summit-2020-industry-conference-
https://www.biospace.com/article/releases/ritter-pharmaceuticals-inc-and-qualigen-inc-announce-merger-agreement
https://www.biospace.com/article/releases/shine-and-iocb-prague-deliver-patient-dose-quantities-of-lutetium-177-to-ge-healthcare-advance-therapeutic-isotope-toward-commercialization
https://www.biospace.com/article/releases/emmes-study-leads-to-pediatric-drug-labeling-change-for-ampicillin
https://www.biospace.com/article/releases/us-food-and-drug-administration-fda-grants-priority-review-of-belantamab-mafodotin-for-patients-with-relapsed-or-refractory-multiple-myeloma
https://www.biospace.com/article/releases/onkos-surgical-partners-with-integrum-to-expand-us-market-for-the-opra-implant-system-a-revolutionary-osseointegration-and-bone-anchored-prosthetic-technology
https://www.biospace.com/article/releases/royal-biologics-announces-the-launch-of-cryo-cord-the-first-non-dmso-viable-umbilical-cord-graftdebuts-at-the-ny20-foundation-for-podiatric-medicine-meeting
https://www.biospace.com/article/releases/clene-nanomedicine-announces-first-patient-dosed-in-the-rescue-als-clinical-trial-for-the-treatment-of-amyotrophic-lateral-sclerosis-als-with-lead-nanocatalytic-therapeutic-cnm-au8
https://www.biospace.com/article/releases/propanc-biopharma-receives-advance-overseas-finding-from-innovation-and-science-australia
https://www.biospace.com/article/releases/updates-on-reducer-and-tiara-programs-will-be-presented-at-advanced-cardiovascular-intervention-2020-meeting
https://www.biospace.com/article/releases/medical-marijuana-inc-subsidiary-hempmeds-flagship-product-real-scientific-hemp-oil-featured-in-us-weekly
https://www.biospace.com/article/releases/trovagene-to-present-new-clinical-data-for-onvansertib-in-metastatic-kras-mutated-colorectal-cancer-at-asco-2020-gastrointestinal-cancers-symposium
https://www.biospace.com/article/releases/vallon-pharmaceuticals-presents-positive-data-from-pilot-intranasal-human-abuse-study-of-its-investigational-abuse-deterrent-stimulant-adair-at-the-american-professional-society-of-adhd-and-related-disorders-apsard-annual-meeting
https://www.biospace.com/article/releases/lsne-leon-completes-successful-fda-pre-approval-inspection-for-sterile-injectable
https://www.biospace.com/article/releases/french-hemovigilance-report-highlights-safety-and-effectiveness-of-intercept-platelets-during-first-full-year-of-100-percent-production-and-routine-use
https://www.biospace.com/article/releases/seattle-genetics-achieves-milestone-following-european-commission-approval-of-roche-s-polivy-polatuzumab-vedotin-
https://www.biospace.com/article/almost-50-non-oncology-drugs-found-to-kill-cancer-cells
https://www.biospace.com/article/releases/regenerx-partner-receives-patent-for-reducing-diabetic-induced-vascular-dysfunction-in-korea
https://www.biospace.com/article/releases/revian-presents-leading-clinical-trial-results-for-new-hair-loss-treatment
https://www.biospace.com/article/getting-to-the-root-of-the-disease-developing-drugs-against-the-hard-to-target-wnt-pathway
https://www.biospace.com/article/releases/oramed-appoints-dr-jay-skyler-to-scientific-advisory-board
https://www.biospace.com/article/releases/genprex-receives-u-s-fda-fast-track-designation-for-gene-therapy-that-targets-lung-cancer
https://www.biospace.com/article/releases/oncology-analytics-announces-partnership-agreement-with-humana-puerto-rico
https://www.biospace.com/article/releases/bayer-to-showcase-new-data-including-research-in-immuno-oncology-at-asco-gi-cancers-symposium-2020
